Kanamycin is an aminoglycoside antibiotic used mainly to treat severe bacterial infections and multidrug-resistant tuberculosis (MDR-TB). It is generally reserved for serious infections where other, less toxic antibiotics are ineffective. Kanamycin works by inhibiting bacterial protein synthesis, leading to bacterial death. It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as anti-infectives, antibacterials, antibiotics and antituberculars. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Kanamycinum and Kanamycins. Its PubChem CID is 6032.
Kanamycin
| CAS No | 59-01-8 |
|---|---|
| Molecular Formula | C18H36N4O11 |
| Molecular Weight | 484.50 g/mol |
| Synonyms | (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Kanamycin is an aminoglycoside antibiotic used mainly to treat severe bacterial infections and multidrug-resistant tuberculosis (MDR-TB). It is generally reserved for serious infections where other, less toxic antibiotics are ineffective.
The listed CAS number is 59-01-8.
The listed molecular formula is C18H36N4O11.
The listed molecular weight is 484.50 g/mol.
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol.
The source lists Kanamycinum and Kanamycins.